PEP-CTN A Phase I study to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of AZD1390 (NSC# 852149, IND# 172675) when combined with focal radiation in pediatric patients with High Grade Glioma Pediatric CIRB Active Available to Open